Next |
home / stock / btai / btai message board
Subject | By | Source | When |
---|---|---|---|
BioXcel Shares Drop Premarket Following Results for Phase | realfast95 | investorshub | 06/29/2023 12:02:20 PM |
$BTAI MomentumIts gaining | realfast95 | investorshub | 06/28/2023 3:11:47 PM |
Price gaining | Penny chatter | investorshub | 06/28/2023 6:01:26 AM |
$BTAI must see | realfast95 | investorshub | 06/25/2023 1:06:15 AM |
$BTAI Long and strong lets hope im right | realfast95 | investorshub | 06/24/2023 1:46:46 PM |
is it bear time? Or do we go bull? | realfast95 | investorshub | 06/24/2023 6:16:39 AM |
$BTAI The trading last trade up | realfast95 | investorshub | 06/23/2023 8:56:57 PM |
$BTAI short squeeze | realfast95 | investorshub | 06/23/2023 6:44:22 PM |
$BTAI MomentumIts now up | realfast95 | investorshub | 06/23/2023 9:10:04 AM |
Price trading | realfast95 | investorshub | 06/19/2023 7:50:39 AM |
$BTAI got some short data | realfast95 | investorshub | 06/16/2023 11:02:16 AM |
$BTAI The gaining | lettruthringout | investorshub | 06/16/2023 12:59:14 AM |
short data if anyone is interested | MDizzle | investorshub | 06/15/2023 3:16:56 PM |
$BTAI oh yeah news for the day | realfast95 | investorshub | 06/14/2023 11:51:06 PM |
$BTAI MomentumIts now up | Alan Brown | investorshub | 06/14/2023 8:27:51 AM |
$BTAI should we be shorting? | lettruthringout | investorshub | 06/12/2023 11:50:00 PM |
When is this gonna take off? | realfast95 | investorshub | 06/12/2023 7:13:41 PM |
$BTAI The gaining up | realfast95 | investorshub | 06/09/2023 5:10:50 PM |
$BTAI Price trading | realfast95 | investorshub | 06/06/2023 12:00:05 AM |
Looks pretty positive | lettruthringout | investorshub | 06/05/2023 10:53:21 PM |
News, Short Squeeze, Breakout and More Instantly...
BioXcel Therapeutics Inc. Company Name:
BTAI Stock Symbol:
NASDAQ Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Advancing TRANQUILITY and SERENITY program plans for two pivotal Phase 3 trials to expand BXCL501 market potential in acute treatment of agitation Strengthened intellectual property portfolio for BXCL501 with grant of two new patents, in Japan and the U.S. Completed $25 million re...